nach oben

Reactions Weekly

Erschienen in:

01.07.2018 | Case report

Monoclonal antibodies

Various toxicities: 9 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Excerpt

In a retrospective study of 104 patients, 9 patients [ages and sexes not stated] were described, who developed hypersensitivity reaction following administration of rituximab, bretuximab vedotin [bretuximab], obinituzumab or tocilizumab. Additionally, the patients developed nausea, vomiting, chills, dry heaves, throat and chest tightness, back pain, itchy throat, rigors, hypertension, tachycardia or chest pain during desensitisation protocol [routes, dosages and outcomes not stated; not all durations of treatments to reactions onsets stated]. …

Isabwe GAC, et al. Hypersensitivity reactions to therapeutic monoclonal antibodies: Phenotypes and endotypes. Journal of Allergy and Clinical Immunology 142: 159-170e2, No. 1, Jul 2018. Available from: URL: http://doi.org/10.1016/j.jaci.2018.02.018 - USA

Titel: Monoclonal antibodies
Various toxicities: 9 case reports
Publikationsdatum: 01.07.2018
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2018
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-018-49659-y

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Monoclonal antibodies

Various toxicities: 9 case reports

Excerpt

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2018

Pazufloxacin

Antineoplastics

Aspirin

Bendamustine/Dexamethasone/Rituximab

Afatinib

BCG